Core summary of product characteristics for human tetanus immunoglobulin for intramuscular use

Current effective version

PDF iconAdopted guideline

Reference numberCPMP/BPWG/3730/02
Published27/07/2005
Effective from01/02/2006
KeywordsHuman tetanus immunoglobulin, post exposure prophylaxis, clinically manifest tetanus
DescriptionThis document describes the information to be included in the summary of product characteristics for human tetanus immunoglobulin for intramascular use.


Related content


How useful was this page?

Add your rating